Thanks, John. Before discussing our recent results for Q3, let me first cover the status of our refinancing efforts. Last night, we were very pleased to announce that we entered into a new $222 million credit facility with a new syndicate of lenders, which replaces our prior credit facility and which is expected to be funded today, June 18. With July 31, 2028 as its maturity date, we have significantly pushed out our repayment obligations by about four years. And by adding an asset-based revolver component to the facility, have immediately enhanced our liquidity. As a result of entering this new credit facility, we are able to once again reclass a major portion of our outstanding debt back to its long-term status. The new credit facility itself consists of a committed $162 million term loan facility and a $60 million revolver loan facility, backed by our eligible receivables and inventory. Outstanding borrowings at close approximate $187 million, reflecting $25 million drawn on the revolver. At close, our available sources of liquidity approximate $63 million, consisting of qualified cash and cash equivalents and excess availability under the revolver, both as defined under the credit agreement of approximately $28 million and $35 million, respectively. Interest on the term loan facility currently approximates SOFR plus 9.5%, whereas interest on the asset-based revolver currently approximates SOFR plus 5%. Blended, the rate currently approximates 14%. Interest on the term loan is dependent on a pricing grid based on our net leverage ratio, and interest on the revolver is dependent on a pricing grid based on our average revolver usage, both as defined in the agreement. Our first covenant testing period is July 31, 2024. At such date, our maximum net leverage ratio is set at 3.25 times trailing 12 months EBITDA. As for the minimum fixed charge coverage ratio, that is initially set at 1.2 times. The first step-down in the net leverage ratio to 3.15 occurs on July 31, 2025. And the first uptick in our fixed charge coverage ratio to 1.25 occurs on April 30, 2025. Other financial covenants we need to maintain include an initial minimum trailing 12-month EBITDA of $35 million starting in October of 2025 and a minimum average liquidity of $20 million. In connection with entering into the new credit facility, we exchanged our Series B convertible preferred shares for a new series of B-1 convertible preferred shares. The new Series B-1 convertible preferred shares reflect certain changes to consent rights and existing put rights related to payments upon a change of control following specified asset sales, in each case consistent with the terms of the new credit facility. The powers, preferences and rights of the Series B-1 convertible preferred stock are substantially the same as those of the Series B. We do not receive any cash proceeds from the issuance of the Series B-1 shares, and importantly, as I'm sure some might ask, the preferred holders conversion price and interest rate did not change. Now the documents themselves are lengthy, so I'm not going to run down each and every term in the agreement. I just covered a good amount of ground on the key terms and strongly urge investors to read these documents, which are being filed in the Form 8-K with the SEC today. Entering into the new credit facility was a key milestone not only for our company but for our customers, our vendors, our dedicated employees who got this over the finish line. We are very pleased to have finally resolved a significant overhang on our business and expect the new credit facility to contribute significantly to enhancing our liquidity and business prospects. With this refinancing now in the rearview mirror, we can get back to the tasks at hand of growing our business, liquidating our unbilled receivables, and increasing value for our shareholders. Now let's talk about Q3 results. Consolidated net sales were $128.1 million, compared to $134.2 million in the second quarter of fiscal 2024 and $136.3 million in the third quarter of fiscal '23. Net sales during our third quarter of fiscal 2024, primarily in our Satellite and Space Communications segment, continue to reflect challenging business conditions stemming principally from our efforts during the quarter to refinance our prior credit facility, which temporarily slowed down our receipt of components from suppliers and our ability to deliver finished products during the quarter. While we have made significant progress towards resolving such conditions by entering into our new credit facility, net sales related to certain orders in our backlog shifted to future periods. Also, as an important reminder, net sales in our Satellite and Space Communications segment for our third quarter reflect the absence of PST, which was divested on November 7, 2023. For the three months ended April 30, 2024, net sales in our Satellite and Space Communications segment primarily reflect higher net sales of our troposcatter solutions to U.S. government and customers, including progress toward delivering next-generation troposcatter terminals to both the U.S. Marine Corps and U.S. Army, more than offset by lower net sales of high-power solid-state amplifiers related to the PST divestiture, COMET tropo terminals to an international customer, and VSAT SATCOM equipment for the U.S. Army. Our book-to-bill ratio measure defined as bookings divided by net sales in this segment for the three months ended April 30, 2024 was 0.85 times. During the third quarter of fiscal 2024, this segment was awarded over $13.5 million of funded orders from the U.S. Army for VSAT equipment and related services, over $6 million of funding from the U.S. Army for cyber training related solutions, over $5.5 million in operational support and maintenance orders from the Japan Aerospace Exploration Agency, over $5 million of funding from a Canadian customer to upgrade a previously deployed troposcatter system, as well as an order from an international military who is evaluating our COMET troposcatter solutions. We believe that this new international customer, along with the two other new international customers that placed orders in our second quarter of fiscal 2024 to evaluate our next-generation modular transportable transmission systems, could lead to larger scale tropo opportunities in the future. As for our Terrestrial and Wireless Network segment, compared to the comparable period of the prior year, Q3 fiscal 2024 reflects higher net sales of our NG-911 and call handling services, offset in part by lower net sales of our location-based solutions. Our book-to-bill ratio in this segment for the three months ended April 30, 2024 was 0.72 times. Key bookings include a multiyear extension for critical NG-911 services for a large county in a Midwestern state valued at over $10 million and an extension of our short messaging service software engineering services to a large international mobile network operator valued at over $7 million, and a multiyear NG-911 call handling services contract aggregating $4 million for PSAPs located in Canada. Additionally, as John referenced before, subsequent to our quarter-end, we entered into a contract with the Commonwealth of Massachusetts for the continued operation and maintenance of the state's NG-911 system. This new contract has an initial five-year term from August 1, 2024 through July 31, 2029, and includes one option to renew for a five-year period through July 31, 2034. Including the option period, the total contract value could potentially exceed $250 million. We are very honored to have been selected again to be a trusted solutions provider to the Commonwealth. This competitive win serves to highlight the strong value proposition of our critical communications infrastructure services and significantly enhances our revenue visibility into the future. Gross margins for the quarter were 30.4%, compared to 32.2% in our second quarter of fiscal '24 and 31.7% in the third quarter of fiscal '23. We reported a GAAP operating loss in Q3 fiscal '24 of $3.5 million, compared to an operating loss of $5.3 million in Q3 of fiscal '23. While both quarters included restructuring charges, GAAP operating loss in the more recent quarter includes $2.5 million of CEO transition costs. As explained in more detail and reconciled in our Form 10-Q for the quarter, we utilize a non-GAAP measure that we refer to as adjusted EBITDA. For Q3 fiscal '24, adjusted EBITDA was $11.9 million or 9.3% of related net sales, as compared to $12.5 million or 9.2% that we achieved in Q3 of fiscal '23. The decrease in adjusted EBITDA in dollars reflects lower research and development expenses in both of our reportable operating segments, more than offset by lower consolidated net sales and lower consolidated gross profit both in dollars and as a percentage of consolidated net sales, and higher unallocated SG&A expenses due to our One Comtech and people strategies initiatives. As we enter the fourth quarter of fiscal 2024, business conditions continue to be challenging and the operating environment is largely unpredictable. In light of these business conditions and resulting challenges, while we are pleased to have successfully closed on our refinancing of the prior credit facility, we do anticipate variability from time to time as we move through our One Comtech transformation and are targeting net sales and adjusted EBITDA for our fourth quarter of fiscal 2024 to be similar to our third quarter of fiscal 2024. Such expectation considers our strong backlog of $653.4 million as of April 30, 2024, our revenue visibility of approximately $1.5 billion, and the timing of our refinancing of the prior credit facility today being so close to our fiscal year-end. Now let me turn the call back over to John. John?